T. Rowe Price Associates »

Eagle Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $50k 13k 3.76
2024-06-30 $75k 13k 5.64
2024-03-31 $83k 16k 5.27
2022-12-31 $465k 16k 29.26
2022-03-31 $648k 13k 49.51
2021-12-31 $676k 13k 50.95
2021-09-30 $752k 14k 55.81
2021-06-30 $577k 14k 42.79
2021-03-31 $628k 15k 41.76
2020-12-31 $924k 20k 46.57
2020-09-30 $1.1M 26k 42.48
2020-06-30 $901k 19k 47.96
2020-03-31 $931k 20k 46.01
2019-12-31 $948k 16k 60.11
2019-09-30 $864k 15k 56.57
2019-06-30 $836k 15k 55.65
2019-03-31 $757k 15k 50.46
2018-12-31 $602k 15k 40.27
2018-09-30 $910k 13k 69.31
2018-06-30 $682k 9.0k 75.70
2018-03-31 $473k 9.0k 52.72
2017-12-31 $476k 8.9k 53.46
2017-06-30 $4.1M 51k 78.89
2017-03-31 $512k 6.2k 83.00
2016-12-31 $886k 11k 79.33
2016-09-30 $658k 9.4k 69.96